Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
A phase 1/2 trial of Gedatolisib, Darolutamide in prostate cancer, run by Celcuity Inc, now recruiting.
Overview
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer is a phase 1/2 interventional study registered as NCT06190899 by Celcuity Inc, with 54 participants planned, started 2024-01-01 and due to reach its primary completion in 2028-01. Interventions recorded: Gedatolisib, Darolutamide. Conditions listed: mCRPC (Metastatic Castration-resistant Prostate Cancer), Genital Diseases, Male, Urogenital Diseases, Male, Prostatic Disease. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialPhase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Shares Celcuity, Gedatolisib.
- TrialGedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
Shares Celcuity, Gedatolisib.
- TrialA Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer
Shares Darolutamide, Prostate cancer.
- TrialA Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have Hi
Shares Darolutamide, Prostate cancer.
- TrialA Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Shares Darolutamide, Prostate cancer.
- TrialTulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in
Shares Darolutamide, Prostate cancer.
- TrialA Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer
Shares Darolutamide, Prostate cancer.
- TrialARASENS
Shares Darolutamide, Prostate cancer.